Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

Insider Trades & Whales

Insider trades are parsed from SEC Form 4 filings (first-party). The ownership breakdown below is computed first-hand from SEC 13F-HR + Form 4 (institutions from 13F, insiders from Form 4). For the full filer list and quarter-over-quarter position changes, see the Institutional (13F) tab.

Ownership Breakdown

Insiders 12.31%Institutions 48.77%120 filers

Top Institutions

Form 4 Transactions

50 most recent
DateInsiderTitleCodeSharesPriceValue
May 13, 2026Aharon GilDirectorA22,500$0.0000$0.00
May 13, 2026CZEREPAK ELIZABETHDirectorA22,500$0.0000$0.00
May 13, 2026Martell Bridget ADirectorA22,500$0.0000$0.00
May 13, 2026SALAMON STEVEN A JDirectorA22,500$0.0000$0.00
May 13, 2026Sylvester John RichardDirectorA22,500$0.0000$0.00
Mar 6, 2026Pennell SandraChief Financial OfficerP5,533$9.0400$50.02K
Mar 2, 2026MICHEL GERARD JCHIEF EXECUTIVE OFFICERP11,200$8.9562$100.31K
Feb 17, 2026MICHEL GERARD JCHIEF EXECUTIVE OFFICERA97,500$0.0000$0.00
Feb 17, 2026MICHEL GERARD JCHIEF EXECUTIVE OFFICERA195,000$0.0000$0.00
Feb 17, 2026Vukovic VojoCHIEF MEDICAL OFFICERA28,250$0.0000$0.00
Feb 17, 2026Vukovic VojoCHIEF MEDICAL OFFICERA56,500$0.0000$0.00
Feb 17, 2026Rook Martha S.CHIEF OPERATING OFFICERA28,250$0.0000$0.00
Feb 17, 2026Rook Martha S.CHIEF OPERATING OFFICERA56,500$0.0000$0.00
Feb 17, 2026Muir KevinGM INTERVENTIONAL ONCOLOGYA28,250$0.0000$0.00
Feb 17, 2026Muir KevinGM INTERVENTIONAL ONCOLOGYA56,500$0.0000$0.00
Feb 17, 2026Hoffman David L.GEN'L COUNSEL, CCO & SECYA28,250$0.0000$0.00
Feb 17, 2026Hoffman David L.GEN'L COUNSEL, CCO & SECYA56,500$0.0000$0.00
Feb 17, 2026Pennell SandraChief Financial OfficerA28,250$0.0000$0.00
Feb 17, 2026Pennell SandraChief Financial OfficerA56,500$0.0000$0.00
Nov 21, 2025Sylvester John RichardDirectorP4,386$8.8900$38.99K
Nov 11, 2025MICHEL GERARD JCHIEF EXECUTIVE OFFICERP11,500$8.5260$98.05K
Jun 12, 2025Vukovic VojoCHIEF MEDICAL OFFICERM42,000$0.0000$0.00
Jun 12, 2025Vukovic VojoCHIEF MEDICAL OFFICERM42,000$4.7800$200.76K
May 15, 2025Aharon GilDirectorA22,500$0.0000$0.00
May 15, 2025Martell Bridget ADirectorA22,500$0.0000$0.00
May 15, 2025Sylvester John RichardDirectorA22,500$0.0000$0.00
May 15, 2025CZEREPAK ELIZABETHDirectorA22,500$0.0000$0.00
May 15, 2025SALAMON STEVEN A JDirectorA22,500$0.0000$0.00
May 5, 2025Rosalind Advisors, Inc.DirectorX400,000$10.0000$4.00M
May 5, 2025SALAMON STEVEN A JDirectorX400,000$10.0000$4.00M
May 5, 2025Aharon GilDirectorX400,000$10.0000$4.00M
Feb 7, 2025MICHEL GERARD JCHIEF EXECUTIVE OFFICERA390,000$0.0000$0.00
Feb 7, 2025Vukovic VojoCHIEF MEDICAL OFFICERA113,000$0.0000$0.00
Feb 7, 2025Rook Martha S.CHIEF OPERATING OFFICERA113,000$0.0000$0.00
Feb 7, 2025Muir KevinGM INTERVENTIONAL ONCOLOGYA113,000$0.0000$0.00
Feb 7, 2025Pennell SandraChief Financial OfficerA113,000$0.0000$0.00
Feb 7, 2025Hoffman David L.GEN'L COUNSEL, CCO & SECYA113,000$0.0000$0.00
Dec 24, 2024Rosalind Advisors, Inc.DirectorM603,954$9.9900$6.03M
Dec 24, 2024Rosalind Advisors, Inc.DirectorC250,000$10.0000$2.50M
Dec 24, 2024Aharon GilDirectorM603,954$9.9900$6.03M
Dec 24, 2024Aharon GilDirectorC250,000$10.0000$2.50M
Dec 24, 2024SALAMON STEVEN A JDirectorM603,954$9.9900$6.03M
Dec 24, 2024SALAMON STEVEN A JDirectorC250,000$10.0000$2.50M
Oct 30, 2024Rosalind Advisors, Inc.DirectorH0$0.0000$0.00
Oct 30, 2024Rosalind Advisors, Inc.DirectorM500$1000.0000$500.00K
Oct 30, 2024SALAMON STEVEN A JDirectorH0$0.0000$0.00
Oct 30, 2024SALAMON STEVEN A JDirectorM500$1000.0000$500.00K
Oct 30, 2024Aharon GilDirectorH0$0.0000$0.00
Oct 30, 2024Aharon GilDirectorM500$1000.0000$500.00K
Oct 22, 2024MICHEL GERARD JCHIEF EXECUTIVE OFFICERM16,666$0.1250$2.08K